RedHill Biopharma Ltd (RDHL)

[tykundegex]

Depends what you call a while. For a biotech, I'd say there are a few close milestones:

next month:
* top line results from Phase 2a for RHB-104 for MS

within ~6 months:
* interim efficacy results for RHB-104 for Crohn's, with an early stop possibility
* top line Phase 3 results Bekinda for GI
* top line Phase 2 results for Bekinda for IBS-D

And just now I saw they have snuck in a "potential acquisition of certain commercial rights to GI asset currently on the market in the U.S." into their Nov Corporate Presentation as a Q4 milestone.. hadn't seen that before. Of course, that may not move the share price in any particular direction (may even cause it to drop, depending on the terms).